Elemene treatment for NSCLC with multiple CNS metastases: a case report and literature review
Yushan Han1, Xia Zhang2, Yishan Lu3,4
1Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China, zhangbin_dlmu@163.com; gaoyajie100@126.com.
Abstract:
CNS metastases are common in patients with non-small-cell lung cancer (NSCLC) and is associated with poor prognosis. In NSCLC patients with EGFR mutations, and ALK fusion oncogene, chemotherapy is ineffective; however, targeted and pulse therapies may be used as alternative treatment options. Elemene can cross the blood-brain barrier and enter the brain tissue. In this paper, treatment consisting of elemene injections in a case of NSCLC with brain metastases, spinal metastases and a possible complication of leptomeningeal metastases is reported, and the efficacy of elemene in treating NSCLC with CNS metastases was investigated.
Insights
Elemene injections show promise for treating non-small-cell lung cancer (NSCLC) that has spread to the central nervous system (CNS). This approach may offer a new option for patients with brain and spinal metastases.
Area of Science:
- Oncology
- Neurology
- Pharmacology
Background:
- Central nervous system (CNS) metastases are a frequent and serious complication of non-small-cell lung cancer (NSCLC), significantly worsening patient prognosis.
- Standard chemotherapy is often ineffective for NSCLC with EGFR mutations or ALK fusion, necessitating alternative therapeutic strategies.
Observation:
- Elemene, a compound known to cross the blood-brain barrier, was administered via injection to a patient with NSCLC.
- The patient presented with extensive metastases, including within the brain, spinal cord, and potential leptomeningeal involvement.
Findings:
- The study investigated the efficacy of elemene in managing NSCLC with CNS metastases.
- Elemene demonstrated potential as a treatment option for these challenging cases.
Implications:
- Elemene's ability to penetrate brain tissue suggests its utility in treating CNS metastases from NSCLC.
- This research opens avenues for exploring targeted therapies for brain metastases in NSCLC patients, particularly those with specific genetic mutations.
More Related Videos
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Data Reporting and Recording
Multiple Allele Traits
CNS Depressants: Alcohol and Nicotine
CNS Depressants: Barbiturates and Benzodiazepines


